Literature DB >> 15669676

Severe neonatal onset of glycogenosis type IV: clinical and laboratory findings leading to diagnosis in two siblings.

B Giuffrè1, R Parini, T Rizzuti, L Morandi, O P van Diggelen, C Bruno, M Giuffrè, G Corsello, F Mosca.   

Abstract

Glycogenosis type IV is an autosomal recessive disease, exceptionally diagnosed at birth: only very few reports of the fatal perinatal neuromuscular form have been described. We report on two sibling male newborns who died at 10 and 4 weeks of age with clinical signs of a systemic storage disease. Prenatal history included polyhydramnios, reduced fetal movements and fetal hydrops, and Caesarean section was performed at 36 weeks of gestational age because of fetal distress. At birth, both babies showed severe hypotonia, hyporeflexia and no spontaneous breathing activity. They never showed active movements, sucking and swallowing and were respirator-dependent until death. A muscle biopsy revealed, in both patients, the presence of PAS-positive and partially diastase-resistant cytoplasmic inclusions containing granular and filamentous amylopectin-like material. This suggested that the stored material consisted of abnormal glycogen. At autopsy, ultrastructural examination of cardiac and skeletal muscle, liver, kidney and brain showed PAS-positive diastase-resistant eosinophilic cytoplasmic inclusions. Determination of branching enzyme activity, in cultured fibroblasts from the second patient, showed markedly reduced enzyme activity, confirming diagnosis of glycogenosis type IV. Our patients showed the full spectrum of both prenatal signs (hydrops, polyhydramnios) and postnatal signs (hypotonia, hyporeflexia, absence of active movements, cardiomegaly), which have been reported previously. They suffered from a very severe form of glycogenosis type IV with clinical and histological involvement of many tissues and organs. Diagnosis was accomplished on the second baby and required several biochemical and histological studies, in order to rule out both neuromuscular disorders and the most common storage diseases with neonatal onset. In our experience, the correct interpretation of the histological findings was essential in the search for the diagnosis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15669676     DOI: 10.1023/b:boli.0000042980.45692.bb

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  29 in total

1.  Glycogenosis. IV. A new cause of infantile hypotonia.

Authors:  H Zellweger; S Mueller; V Ionasescu; S S Schochet; W F McCormick
Journal:  J Pediatr       Date:  1972-05       Impact factor: 4.406

2.  Lack of an alpha-1,4-glucan: alpha-1,4-glucan 6-glycosyl transferase in a case of type IV glycogenosis.

Authors:  B I Brown; D H Brown
Journal:  Proc Natl Acad Sci U S A       Date:  1966-08       Impact factor: 11.205

3.  Lysosomal glycogen storage disease with normal acid maltase.

Authors:  M J Danon; S J Oh; S DiMauro; J R Manaligod; A Eastwood; S Naidu; L H Schliselfeld
Journal:  Neurology       Date:  1981-01       Impact factor: 9.910

4.  Early-onset fetal hydrops and muscle degeneration in siblings due to a novel variant of type IV glycogenosis.

Authors:  P M Cox; L A Brueton; K W Murphy; V C Worthington; P Bjelogrlic; E J Lazda; N J Sabire; C A Sewry
Journal:  Am J Med Genet       Date:  1999-09-10

5.  Primary LAMP-2 deficiency causes X-linked vacuolar cardiomyopathy and myopathy (Danon disease).

Authors:  I Nishino; J Fu; K Tanji; T Yamada; S Shimojo; T Koori; M Mora; J E Riggs; S J Oh; Y Koga; C M Sue; A Yamamoto; N Murakami; S Shanske; E Byrne; E Bonilla; I Nonaka; S DiMauro; M Hirano
Journal:  Nature       Date:  2000-08-24       Impact factor: 49.962

6.  Glycogen branching enzyme deficiency in adult polyglucosan body disease.

Authors:  C Bruno; S Servidei; S Shanske; G Karpati; S Carpenter; D McKee; R J Barohn; M Hirano; Z Rifai; S DiMauro
Journal:  Ann Neurol       Date:  1993-01       Impact factor: 10.422

7.  An improved procedure for diagnosis of Gaucher disease using cultured skin fibroblasts and the chromogenic substrate, 2-hexadecanoylamino-4-nitrophenyl-beta-D-glucopyranoside.

Authors:  R J Barns; A E Clague
Journal:  Clin Chim Acta       Date:  1982-03-26       Impact factor: 3.786

8.  Concomitant branching enzyme and phosphorylase deficiencies. An unusual glycogenosis with extensive neuronal polyglucosan storage.

Authors:  M K Herrick; J L Twiss; G D Vladutiu; G F Glasscock; D S Horoupian
Journal:  J Neuropathol Exp Neurol       Date:  1994-05       Impact factor: 3.685

9.  Structure of glycogens and amylopectins. III. Normal and abnormal human glycogen.

Authors:  B ILLINGWORTH; G T CORI
Journal:  J Biol Chem       Date:  1952-12       Impact factor: 5.157

10.  Marked elevation of plasma chitotriosidase activity. A novel hallmark of Gaucher disease.

Authors:  C E Hollak; S van Weely; M H van Oers; J M Aerts
Journal:  J Clin Invest       Date:  1994-03       Impact factor: 14.808

View more
  2 in total

1.  Neuropathological study of skeletal muscle, heart, liver, and brain in a neonatal form of glycogen storage disease type IV associated with a new mutation in GBE1 gene.

Authors:  C Lamperti; S Salani; S Lucchiari; A Bordoni; M Ripolone; G Fagiolari; M E Fruguglietti; V Crugnola; C Colombo; A Cappellini; A Prelle; N Bresolin; G P Comi; M Moggio
Journal:  J Inherit Metab Dis       Date:  2009-04-08       Impact factor: 4.982

Review 2.  Glycogen storage diseases: new perspectives.

Authors:  Hasan Ozen
Journal:  World J Gastroenterol       Date:  2007-05-14       Impact factor: 5.742

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.